· Simultaneous Multi-Slice (SMS) accelerates advanced neurological MRI applications for the clinical routine
· GOBrain enables clinically validated push-button brain exams in just five minutes1
Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared two new magnetic resonance imaging (MRI) applications – Simultaneous Multi-Slice (SMS) and GOBrain – that are designed to dramatically reduce the time required for MRI examinations of the brain. Shorter scans are increasingly important at a time when brain scans account for approximately 1 out of every 4 MRI examinations, and when the number of brain MRI exams is expected to swell to 45 million worldwide this year.2
Using an innovative technique that acquires MR images simultaneously as opposed to sequentially, Siemens’ new SMS application reduces 2D acquisition times by as much as a factor of 8. Using SMS, physicians can reduce the length of MRI brain examinations, which can vary significantly, to times compatible with the clinical routine (e.g., up to 68 percent for diffusion tensor imaging, or DTI3) and bring clinical relevance to advanced neurological applications. SMS can be used in the treatment of patients who possess limited tolerance for longer scan times, including pediatric or geriatric patients.4 In brain surgery cases, SMS may facilitate surgical mapping and improve efficiency in the OR.
Enabling clinically validated brain examinations in just five minutes,1 the new GOBrain application allows acquisition of clinically essential image orientations and contrasts with a single button-push, thanks in part to Siemens’ high-channel density coils and the company’s unique MRI scanning software DotGO. GOBrain helps improve patient throughput and potentially reduce costs per scan. Shorter scan times, which are better tolerated by patients, can help curb lengthy and potentially expensive rescans as well as potentially reduce sedation.5
“Siemens Healthcare is excited to offer the Simultaneous Multi-Slice (SMS) and GOBrain applications, which can enable our customers to dramatically cut MRI scan acquisition times and provide a significantly more patient-friendly brain MRI examination,” says Murat Gungor, Vice President of Magnetic Resonance at Siemens Healthcare.
The SMS application is available on Siemens’ MAGNETOM Aera 1.5T, MAGNETOM Skyra 3T, and MAGNETOM Prisma and Prismafit 3T MRI systems. The GOBrain application is featured on the MAGNETOM Aera and MAGNETOM Skyra systems.
Contact for journalists
Jeff Bell
Siemens Healthcare
Phone: 610-448-6348; E-mail: jeffrey.t.bell@siemens.com
For more information, please visit: www.usa.siemens.com/mri-neuro
Follow us on Twitter: www.twitter.com/SiemensHealth
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of €7.4 billion. At the end of September 2015, the company had around 348,000 employees worldwide. Further information is available on the Internet at www.siemens.com.
